Last reviewed · How we verify

Trilafon — Competitive Intelligence Brief

Trilafon (PERPHENAZINE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Phenothiazine [EPC]. Area: Neuroscience.

marketed Phenothiazine [EPC] D(3) dopamine receptor Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Trilafon (PERPHENAZINE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Trilafon TARGET PERPHENAZINE marketed Phenothiazine [EPC] D(3) dopamine receptor 1957-01-01
Pramipexole (Mirapex) Pramipexole (Mirapex) Massachusetts General Hospital marketed Dopamine agonist D2 dopamine receptor, D3 dopamine receptor
Prolixin Decanoate FLUPHENAZINE DECANOATE Bristol-Myers Squibb marketed Phenothiazine D(2) dopamine receptor 1972-01-01
Thioridazine-2-Sulfoxide MESORIDAZINE marketed Phenothiazine Histamine H1 receptor 1970-01-01
Moditen Enanthate FLUPHENAZINE ENANTHATE Bristol-Myers Squibb marketed Phenothiazine D(3) dopamine receptor 1967-01-01
Prolixin FLUPHENAZINE marketed Phenothiazine D(3) dopamine receptor 1959-01-01
Stelazine TRIFLUOPERAZINE marketed Phenothiazine D(3) dopamine receptor 1959-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Phenothiazine [EPC] class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Trilafon — Competitive Intelligence Brief. https://druglandscape.com/ci/perphenazine. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: